Vemurafenib-induced pulmonary injury

Onkologie. 2013;36(11):685-6. doi: 10.1159/000355643. Epub 2013 Oct 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Female
  • Humans
  • Indoles / adverse effects*
  • Lung Injury / chemically induced*
  • Lung Injury / diagnosis
  • Lung Injury / prevention & control*
  • Melanoma / complications
  • Melanoma / drug therapy*
  • Melanoma / secondary*
  • Middle Aged
  • Sulfonamides / adverse effects*
  • Treatment Outcome
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib